{"ticker":"ALNY","companyName":"Alnylam Pharmaceuticals, Inc.","fiscalYear":2025,"executiveName":"Yvonne L. Greenstreet","executiveTitle":"M.D. Chief Executive Officer (principal executive officer)","totalComp":14867600,"salary":1404200,"stockAwards":5512500,"optionAwards":4363380,"nonEquityIncentive":3562500,"otherComp":25020,"yoyChangePct":29.362558155115693,"source":{"filingType":"DEF 14A","accession":"0001628280-26-023923","filingDate":"2026-04-06","filingUrl":"https://www.sec.gov/Archives/edgar/data/1178670/000162828026023923/alny-20260406.htm"},"lastUpdated":"2026-06-04T07:03:19.738Z","yoy_total_comp_pct":29.362558155115693}